Be the first to know

Never miss an update from Palatin Technologies. Did you know that during reporting season, the announcements from NYSEMKT:PTN often move the market?

Palatin Technologies (NYSEMKT:PTN) Company Logo

By joining StockLight, you agree to our Terms & Conditions and Privacy Policy
Create Alert Follow PTN

Palatin Technologies (PTN)

US NYSEMKT:PTN (106.1M)

0.51
+0.05 (10.22%)
4:22pm EST
LOADING
Loading price chart..

Summary

Current Price: $0.51
52w High/Low: $0.46 - 1.78
Market Cap: 106.1M
Price/Earnings: 2.62
Dividend Yield: -
Volume/Average: 2.7M - 1.4M
Palatin Technologies (NYSEMKT:PTN) Company Logo
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems... More
Palatin Technologies (NYSEMKT:PTN) Company Logo

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, a peptide melanocortin receptor 4 agonist for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Annual Reports

Palatin Technologies (PTN) 10-K Annual Report Sep 12th 2019
2019
(1014kb)
Palatin Technologies (PTN) 10-K Annual Report Sep 13th 2018
2018
(989kb)
Palatin Technologies (PTN) 10-K Annual Report Apr 13th 2018
2018
(359kb)
Palatin Technologies (PTN) 10-K Annual Report Sep 25th 2017
2017
(690kb)
Palatin Technologies (PTN) 10-K Annual Report Sep 19th 2016
2016
(675kb)

Dividend History

No dividends found.

Quantitative Ratios

Stock Ratios Locked
You viewed 3 companies today
Ratios will be unlocked
again tomorrow or;

Unlock these ratios,
configure alerts
and much more...

Download StockLight

All Ratios, Alerts and other features are available in our iOS and Android apps:
Download on iOS Download on Android

We are working on updating this web app to fully enable Quantitative Ratios. All other current web features including annual reports, price sensitive announcements, dividends and earnings transcripts are free to use here on our web app.
Implied Growth
38.3%
 
-23.7%
 
 
Industry Avg
PTN

ATTRACTIVE: Palatin Technologies exhibits an implied growth ratio which is less than the industry average for biotechnology stocks listed on the NYSEMKT. PTN calculation: 10% - ($0.17 / $0.51) = -23.3% more
Price / Book
2.8
 
1.2
 
 
Industry Avg
PTN

ATTRACTIVE: Palatin Technologies exhibits a price/book ratio which is less than the industry average for biotechnology stocks listed on the NYSEMKT. more
Price / Earnings
2.7
 
2.7
 
 
Industry Avg
PTN

AVERAGE: Palatin Technologies's price/earnings ratio of 2.7 is within a 15% range of the industry average for biotechnology stocks listed on the NYSEMKT. more
Price / Sales
5.7
 
1.8
 
 
Industry Avg
PTN

ATTRACTIVE: Palatin Technologies exhibits a price/sales ratio which is less than the industry average for biotechnology stocks listed on the NYSEMKT. more

Company News

Q2 2020 Earnings Call Transcript
February 12th, 2020

Contents:

Why Palatin Technologies Stock Dropped as Much as 21.5% Today
June 25th, 2019 - Motley Fool

A high-profile analyst questioned the company's recent FDA approval.

3 Drug Stocks That Could Win From Key FDA Approvals in June
June 4th, 2019 - Motley Fool

Two hope to pick up additional indications for existing blockbuster drugs, while another could score a big victory for a new drug.

Palatin Technologies (PTN) Q3 2019 Earnings Call Transcript
May 10th, 2019 - Motley Fool

PTN earnings call for the period ending March 31, 2019.